RainDance Technologies is a leading life sciences company developing innovative products that enable more accurate, reliable, cost-effective and early detection of disease and predisposition risk in order to improve human healthcare. Today, RainDance is focused on better healthcare outcomes and lowering costs for the research, diagnosis and treatment of cancers and inherited diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/29/13 | $20,000,000 | Series E |
Acadia Woods Partners Mohr Davidow Ventures Myriad Genetics Quaker BioVentures Sectoral Asset Management | undisclosed |
